✦ LIBER ✦

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension

✍ Scribed by J. P. Ollivier; P. Durier; J. L. Bussiere; J. L. Gayet

Publisher: Springer
Year: 1990
Tongue: English
Weight: 349 KB
Volume: 38
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf01409489

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension

✍ Terrence David Ruddy; James M. Wright; Daniel Savard; S. Paul Handa; Arun Chocka 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 859 KB

Safety and tolerability of once-daily ve

Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease

✍ Roy W. Jones; Antony Bayer; Fraser Inglis; Andrew Barker; Ravinder Phul 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease (AD). ## Method This 12‐week, randomised, double‐blind study, investigated three dosing schedules of memantine: OD1 (20 mg once

Comparison of once daily felodipine 10 m

Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension

✍ W. Koenig; M. Sund; L. Binner; R. Hehr; J. Rosenthal; V. Hombach 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 309 KB

The efficacy of extended release felodipine 10 mg (ER) o.d., a new dihydropyridine calcium antagonist, and 25 mg hydrochlorothiazide (HCTZ) o.d. have been compared in a randomized, double-blind, crossover trial in 28 mildly to moderately hypertensive subjects (supine diastolic blood pressure, BP, gr

Efficacy and safety of a new combination

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial

✍ L. Guenther; F. Cambazard; P.C.M. Van De Kerkhof; E. Snellman; K. Kragballe; A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr

A double-blind comparison of once-daily

A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension

✍ Ming-Fong Chen; Chi-Yu Yang; Wen-Jone Chen; Chii-Ming Lee; Chau-Chung Wu; Chiau- 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 537 KB

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop